The role of mRNA 5' end capping in the transcriptional regulation of gene expression in eukaryotic cells.
The role of mRNA 5' end capping in the transcriptional regulation of gene expression in eukaryotic cells.
批准号:
2098601
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The 5' RNA m7G cap is an essential modification of the RNA Polymerase II-dependent (Pol II) transcripts. An efficient mRNA capping is crucial for mRNA stability as it protects the RNA from 5'-3' degradation. The cap functions also as a platform for the Cap Binding Complex (CBC) which is essential for cellular RNA metabolism including nuclear export, degradation, and translation. Although the m7G cap has a crucial function in the mRNA biogenesis, very little is known about its direct role in transcription and ultimately, in gene expression. Previous reports indicate that defects in mRNA capping may affect the transition from transcription initiation to elongation or trigger premature transcription termination. Thus, the project will investigate in the model organism Saccharomyces cerevisiae how the mRNA cap, the capping enzymes and the capping process regulate transcription and RNA synthesis in eukaryotic cells. The student will employ chromatin immunoprecipitation (ChIP-seq) analysis to test genomic positions of Pol II phosphoisoforms as well as RNA analyses of steady-state (RNA-seq and direct RNA-seq) and nascent RNA (4tU RNA-seq) in cap-deficient cells. These approaches will provide a comprehensive analysis of how m7G cap and the capping impact nuclear RNA biology in eukaryotic cells. The outcomes of this project will reveal if and how RNA cap is related to 5'-3' co-transcriptional degradation and will define a correlation between capping, transcription progression and transcription termination of Pol II-transcribed genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
慢性乙肝功能性治愈mRNA药物专利转让
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵维俊
-
依托单位:
靶向子宫内膜癌的GCNT3 mRNA聚合物纳米递送系统的构建及转化研究
-
批准号:JCZRLH202601886
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
YBX1介导的HOXA9 mRNA稳定性影响c-MYC转录在胃癌进展中的机制研究
-
批准号:2026JJ82359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:卢太亮
-
依托单位:
TET1介导GLI3 mRNA m5C去甲基化修饰负调控ABCA1促动脉粥样硬化
-
批准号:2026JJ81712
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜滢
-
依托单位:
基于mRNA的可调控MSLN-IL-12-CAR T联合表达Mesothelin的溶瘤病毒协同提高对非小细胞肺癌杀伤活性的研究
-
批准号:JCZRMS202601676
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
PUS7介导PCGF5 mRNA假尿苷修饰下调DUSP2表达促进甲状腺未分化癌增殖与转移的机制研究
-
批准号:2026JJ70014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:丁颖
-
依托单位:
基于原位凝胶-LNP复合递送系统的mRNA长效释放机制与效能研究
-
批准号:2026JJ70076
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈启明星
-
依托单位:
清瘟败毒饮通过YBX1/m5C介导的PKM2/LDHA mRNA稳定性下调抑制糖酵解及M1巨噬细胞极化减轻脓毒症肺损伤的机制研究
-
批准号:2026JJ82076
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗柔
-
依托单位:
α-酮戊二酸抑制NSUN2介导GATA4 mRNA m5C修饰调控血管平滑肌细胞衰老相关分泌表型及动脉粥样硬化
-
批准号:2026JJ81921
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谈春芝
-
依托单位:
TRIM25抑制YBX1-m5C介导的TIGAR mRNA稳定调控缺血性脑卒中神经元铁死亡的机制探索
-
批准号:2026JJ81956
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李燕
-
依托单位: